Physician profile
Michael E Billhymer
NPI 1033361100
$1,130.52
in general payments reported to CMS, 2019-2025
8 companies · $585 in 2025
The $585 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $54.67 · 2021: $6.49 · 2023: $12.79 · 2024: $99.35 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $494.58 | 2019-2025 | Anthem |
| Smith+Nephew, INC. | $283.41 | 2025 | Trigen, Evos Mini, Evos |
| Orthofix Medical, INC. | $187.70 | 2020-2025 | Physio-Stim |
| Integra Lifesciences Corporation | $68.95 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $32.15 | 2019-2020 | |
| Impactortho, INC. | $28.15 | 2025 | |
| Abbott Laboratories | $22.72 | 2024 | Eterna |
| Kerecis Limited | $12.86 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Billhymer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.